Medical Research
Blocking Brain Damage from Glioblastoma May Slow Tumor Growth and Extend Cognitive Function
New research from University College London suggests that preventing brain damage caused by glioblastoma could significantly slow tumor progression and preserve cognitive function longer in patients.
New Podcast Explores Neuroplastic Pain Affecting 1.5 Billion People Worldwide
Dr. David Clarke's podcast 'The Story Behind the Symptoms' addresses the growing epidemic of neuroplastic pain conditions through patient interviews and evidence-based Neuroplastic Recovery Therapy, offering alternatives to traditional medical treatments.
Boone Heart Institute to Host Summit Conference 2025 Focused on Preventive Cardiology Advancements
The Boone Heart Institute's Summit Conference 2025 in Denver will bring together healthcare professionals to address atherosclerosis, the world's leading cause of death, through cutting-edge research and clinical innovations in preventive cardiology.
Creative Biolabs Launches Integrated Cell Therapy Platforms to Advance Cancer Immunotherapy
Creative Biolabs has launched fully integrated CAR-T and TIL therapy development platforms, providing researchers and biotech startups with comprehensive services to accelerate the development of next-generation cellular immunotherapies for cancer treatment.
Columbia University Scientists Develop Bacterial Trojan Horse Method to Deliver Anti-Cancer Viruses
Columbia University researchers have engineered bacteria to deliver cancer-killing viruses directly into tumors, bypassing immune system defenses and potentially revolutionizing cancer treatment approaches.
Vaginal Estrogen Tablets Show No Increased Stroke Risk for Postmenopausal Women with Prior Stroke History
A Danish registry study found vaginal estrogen tablets do not increase recurrent stroke risk in postmenopausal women with prior strokes, offering reassurance for safe symptom management in this high-risk population.
ReAlta Life Sciences Gains EMA Orphan Drug Designation for Graft-Versus-Host Disease Treatment
ReAlta Life Sciences received European Medicines Agency Orphan Drug Designation for its drug pegtarazimod, advancing a novel dual-targeting treatment approach for steroid-refractory acute graft-versus-host disease that addresses critical unmet medical needs.
GeoVax Secures Patent for Multi-Antigen COVID-19 Vaccine Technology
GeoVax Labs has obtained a key U.S. patent for its multi-antigen COVID-19 vaccine technology, strengthening its position in developing next-generation vaccines that could provide broader and more durable protection against evolving variants.
Blood Donor Shortage Worsens as Artificial Substitutes Remain Limited to Emergency Use
A critical shortage of blood donors, particularly those with universal O-negative type, persists due to declining participation and demographic shifts, while artificial blood substitutes like ErythroMer remain years away from replacing human donations for most medical needs.
Study Reveals Declining Heart Health Among Older Adults with Cardiovascular Conditions
New research shows significant declines in cardiovascular health among U.S. adults aged 65 and older with high blood pressure, stroke, or heart failure, highlighting critical gaps in blood pressure control and physical activity.
Incannex Healthcare's IHL-42X Shows Promising Phase 2 Results for Sleep Apnea Treatment
Incannex Healthcare Inc. reports significant progress with its IHL-42X treatment for obstructive sleep apnea, achieving up to 83% reduction in apnea events with strong patient-reported outcomes, positioning the company for potential market entry while strengthening its financial position.
Branded Legacy Subsidiary Partners with McMaster University to Evaluate Addiction Treatment Solutions
Branded Legacy's subsidiary Bio-Legacy Evaluative Group has formed a strategic partnership with McMaster University to advance rigorous evaluations and clinical trials for addiction interventions, aiming to reduce overdose deaths and promote recovery.
GeoVax to Showcase Mpox Vaccine Progress at Emerging Growth Conference
GeoVax Labs, Inc. will present updates on its GEO-MVA Mpox vaccine development at the Emerging Growth Conference, highlighting potential regulatory acceleration and manufacturing advantages.
Study Reveals B-Vitamin Supplements Could Offer New Hope for Parkinson’s Disease Patients
A recent study highlights the potential of B-vitamin supplements in addressing some medical needs of Parkinson’s disease patients, suggesting a simple yet effective treatment option.
Clene Inc. to Share Corporate Update at Emerging Growth Conference
Clene Inc. is set to present a corporate update at the Emerging Growth Conference, highlighting its progress in developing treatments for neurodegenerative diseases.
Intensity Therapeutics Pioneers New Cancer Treatment with Minimal Side Effects
Intensity Therapeutics is advancing a novel cancer treatment that directly targets tumors with minimal side effects, offering hope for patients with refractory solid tumors.
Understanding the Risks and Treatments of Benign Brain Tumors in Women
This article highlights the increased risk of benign brain tumors in women and the importance of recognizing early symptoms, while also discussing current treatment options and ongoing research efforts.
New High Blood Pressure Guideline Focuses on Prevention and Early Treatment to Combat CVD Risk
A joint guideline by the American Heart Association and the American College of Cardiology emphasizes early treatment and lifestyle changes to manage high blood pressure, aiming to reduce the risk of cardiovascular diseases and cognitive decline.
CNS Pharmaceuticals Inc. Advances TPI 287 Toward Phase 2 GBM Trial Amid Improved Financials
CNS Pharmaceuticals Inc. reports a slight improvement in Q2 2025 financials, with reduced net losses and increased R&D expenses as it prepares for a Phase 2 trial of TPI 287 for glioblastoma multiforme, highlighting the drug's potential to cross the blood-brain barrier and treat CNS tumors.
New Study Challenges Traditional Psoriasis Severity Classifications
Recent research indicates that psoriasis affecting less than 3% of body surface area may still impose a significant disease burden, prompting a reevaluation of current treatment approaches.
Transformational $3 Million Gift to Advance Women's Heart Health
A $3 million donation from Lee and Valerie Shapiro to the American Heart Association aims to enhance women's heart health through research and awareness campaigns.
New Study Offers Hope for Pediatric Glioma Treatment
A collaborative study between the Broad Institute and the Dana-Farber Cancer Institute has identified a promising treatment approach for pediatric gliomas using FDA-approved inhibitors.
Quantum BioPharma Ltd. Advances MS Treatment with CDMO Agreement for Lucid-MS
Quantum BioPharma Ltd. has taken a significant step towards clinical trials for its oral Lucid-MS treatment for multiple sclerosis by partnering with a leading contract development and manufacturing organization.
Senate Approves Groundbreaking Research on Military Gambling Addiction
The Senate Appropriations Committee has approved a provision to include gambling addiction research in the Department of Defense's Peer-Reviewed Medical Research Program, addressing a critical gap in behavioral health support for servicemembers and veterans.
Breakthrough Lung Cancer Treatment Enhances Chemotherapy with Mitochondrial Transplantation
Researchers in China have developed a novel lung cancer treatment that combines chemotherapy with mitochondrial transplantation to significantly improve treatment efficacy and immune response.
Study Links Ultraprocessed Foods to Increased Health Risks, Calls for Policy Reform
A new Science Advisory from the American Heart Association highlights the adverse health effects of ultraprocessed foods (UPFs), linking them to increased risks of cardiovascular disease, obesity, and diabetes, and calls for research and policy changes to improve public health.
Lantern Pharma Inc. Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule
Lantern Pharma Inc. has successfully completed patient enrollment in Japan for its Phase 2 HARMONIC(TM) trial targeting never-smoker non-small cell lung cancer patients, a significant step towards addressing a critical unmet medical need.
GeoVax Advocates for MVA-Based Vaccines Following HHS mRNA Vaccine Rollback
GeoVax Labs highlights the advantages of its MVA-based multi-antigen vaccine, GEO-CM04S1, as a solution to the limitations of mRNA vaccines identified by the HHS, emphasizing broader and more durable protection against COVID-19 and other viruses.
2025 Rose Gala Aims to Elevate Rare Disease Research and Pediatric Care
The 2025 Rose Gala, hosted by the To Cure A Rose Foundation, is set to raise significant funds for rare disease research and honor Dr. Z. Leah Harris for her contributions to pediatric care, featuring auctions and performances to support the cause.
Quantum BioPharma Ltd. Reports Positive Phase 1 Safety Results for Lucid-MS
Quantum BioPharma Ltd. announces positive Phase 1 safety results for Lucid-MS, a potential treatment for multiple sclerosis, marking a significant step towards efficacy trials and FDA application.